Gabriele Neumann
Pharmaceutics
FluGen
United States of America
Biography
"Dr. Neumann brings both significant academic and industry experiences to FluGen Inc. She is a trained molecular virologist with more than 15 years working with the influenza virus. During her graduate studies in Germany, she developed a system that allows the artificial generation of pieces of influenza virus. This work was instrumental in the breakthrough of “reverse genetics†during her postdoctoral fellowship in Dr. Kawaoka’s research group. Dr. Neumann used this system for the artificial generation of live influenza viruses and for this accomplishment she was awarded the Loeffler-Frosch Award in 2000. Dr. Neumann continues to study the influenza virus life cycle and to devise improved systems for the generation of vaccine viruses. The ability to manipulate influenza viruses builds the foundation for the development of new or improved influenza virus vaccines and antivirals, as proposed by FluGen, Inc. In 2000, Dr. Neumann took her detailed knowledge of and experience with influenza virus research to Wyeth where as a Senior Scientist she worked on the development of FluMistTM/ CAIV-T. In 2002, she rejoined Dr. Kawaoka’s research group, where she currently holds the position of Research Associate Professor."
Research Interest
His research interests include fields like molecular virology